Financhill
Sell
23

RPRX Quote, Financials, Valuation and Earnings

Last price:
$31.13
Seasonality move :
-5.07%
Day range:
$30.45 - $31.70
52-week range:
$24.05 - $34.20
Dividend yield:
2.73%
P/E ratio:
17.25x
P/S ratio:
8.17x
P/B ratio:
1.94x
Volume:
7.3M
Avg. volume:
4.7M
1-year change:
8.32%
Market cap:
$13.5B
Revenue:
$2.3B
EPS (TTM):
$1.80

Earnings Data

Next earnings date for RPRX
May 09
2025
Most recent earnings per share
$0.35
Missed by $0.70
(Feb 11/2025)
Consensus Estimate
$1.05
(Feb 11/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

RPRX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $657.8M -- -- $1.01 --
05/09/2025 Q1 $724.7M -- -- $1.06 --
02/11/2025 Q4 $743.6M $593.6M $0.35 $1.05 -$0.70
11/06/2024 Q3 $731.8M $564.7M $1.21 $0.93 $0.28
08/08/2024 Q2 $645.3M $537.3M $0.23 $0.97 -$0.74
05/09/2024 Q1 $709.4M $568M $0.01 $0.98 -$0.97
02/15/2024 Q4 $674.5M $596.1M $1.10 $1.00 $0.10
11/08/2023 Q3 $618.5M $536.3M $0.16 $0.77 -$0.61
08/08/2023 Q2 $536.6M $538.2M $0.50 $0.81 -$0.31
05/09/2023 Q1 $629.7M $684M $0.76 $1.27 -$0.51
02/15/2023 Q4 -- $565.7M -$1.47 -- --
11/08/2022 Q3 -- $573.5M $0.32 -- --
08/04/2022 Q2 -- $536M $0.70 -- --
05/05/2022 Q1 -- $562M $0.12 -- --
02/15/2022 Q4 -- $575.7M -$0.66 -- --
11/10/2021 Q3 -- $585.8M $0.24 -- --
08/11/2021 Q2 -- $555M $1.08 -- --
05/11/2021 Q1 -- $573M $0.18 -- --
02/17/2021 Q4 -- $572.1M $0.44 -- --
11/11/2020 Q3 -- $538.4M $0.79 -- --
08/12/2020 Q2 -- $510.9M $0.09 -- --
03/31/2020 Q1 -- $500.9M $0.20 -- --
12/31/2019 Q4 -- $457.5M $4.01 -- --
09/30/2019 Q3 -- $464.3M $1.15 -- --
06/30/2019 Q2 -- $457.6M $0.43 -- --
03/31/2019 Q1 -- $434.9M $1.04 -- --
03/20/2017 Q4 -- -- -- -- --
11/14/2016 Q3 -- -- -- -- --
08/08/2016 Q2 -- -- -- -- --
05/05/2016 Q1 -- -- -- -- --
03/21/2016 Q4 -- -- -- -- --
11/09/2015 Q3 -- -- -- -- --
08/10/2015 Q2 -- -- -- -- --

Royalty Pharma PLC Earnings Questions

  • How Much did Royalty Pharma PLC Generate in Revenue Last Quarter?

    Royalty Pharma PLC reported $593.6M worth of top line sales in its most recent quarter.

  • Did Royalty Pharma PLC Beat Earnings Last Quarter?

    Royalty Pharma PLC announced earnings per share of $0.35 which represents a miss of analyst forecast a $1.05 per share.

  • Is Royalty Pharma PLC Profitable?

    Royalty Pharma PLC reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Royalty Pharma PLC EPS Next Year?

    Royalty Pharma PLC's earnings are forecast to grow from $1.91 per share to $4.67 per share next year representing an increase of 144.18%.

  • When is Royalty Pharma PLC's Earnings Date?

    Royalty Pharma PLC's next earnings date is May 9, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Do I Need to Know About Alcoa Stock?
What Do I Need to Know About Alcoa Stock?

Alcoa (AA) is a global leader in aluminum production. Based…

Is ROOT Stock the Next Big Thing?
Is ROOT Stock the Next Big Thing?

Root Holdings (NASDAQ:ROOT) is the parent company of Root Insurance,…

Is Okta a Good Stock to Buy?
Is Okta a Good Stock to Buy?

Okta (NASDAQ:OKTA) is used by some of the largest firms…

Stock Ideas

Sell
37
Is AAPL Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 31x

Sell
37
Is MSFT Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 30x

Sell
31
Is NVDA Stock a Buy?

Market Cap: $2.3T
P/E Ratio: 32x

Alerts

Sell
45
RGC alert for Apr 5

Regencell Bioscience Holdings [RGC] is up 32.59% over the past day.

Sell
25
GDXU alert for Apr 5

MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 27.33% over the past day.

Buy
76
SOXS alert for Apr 5

Direxion Daily Semiconductor Bear 3X Shares [SOXS] is up 23.96% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock